Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Parviz Behnam-Motlagh"'
Autor:
Lorenzo Galluzzi, Ilio Vitale, Laura Senovilla, Ken André Olaussen, Guillaume Pinna, Tobias Eisenberg, Aïcha Goubar, Isabelle Martins, Judith Michels, Gueorgui Kratassiouk, Didac Carmona-Gutierrez, Marie Scoazec, Erika Vacchelli, Frederic Schlemmer, Oliver Kepp, Shensi Shen, Maximilien Tailler, Mireia Niso-Santano, Eugenia Morselli, Alfredo Criollo, Sandy Adjemian, Mohamed Jemaà, Kariman Chaba, Claire Pailleret, Mickaël Michaud, Federico Pietrocola, Nicolas Tajeddine, Thibault de La Motte Rouge, Natalia Araujo, Nadya Morozova, Thomas Robert, Hugues Ripoche, Frederic Commo, Benjamin Besse, Pierre Validire, Pierre Fouret, Angélique Robin, Nicolas Dorvault, Philippe Girard, Sébastien Gouy, Patricia Pautier, Nora Jägemann, Ann-Christin Nickel, Sabrina Marsili, Caroline Paccard, Nicolas Servant, Philippe Hupé, Carmen Behrens, Parviz Behnam-Motlagh, Kimitoshi Kohno, Isabelle Cremer, Diane Damotte, Marco Alifano, Øivind Midttun, Per Magne Ueland, Vladimir Lazar, Philippe Dessen, Hans Zischka, Etienne Chatelut, Maria Castedo, Frank Madeo, Emmanuel Barillot, Juergen Thomale, Ignacio Ivan Wistuba, Catherine Sautès-Fridman, Laurence Zitvogel, Jean-Charles Soria, Annick Harel-Bellan, Guido Kroemer
Publikováno v:
Cell Reports, Vol 2, Iss 2, Pp 257-269 (2012)
Patients with non-small cell lung cancer (NSCLC) are routinely treated with cytotoxic agents such as cisplatin. Through a genome-wide siRNA-based screen, we identified vitamin B6 metabolism as a central regulator of cisplatin responses in vitro and i
Externí odkaz:
https://doaj.org/article/c962346fede94134a0ec7d5f7e6f4ffd
Publikováno v:
Toxins, Vol 2, Iss 10, Pp 2467-2477 (2010)
A major problem with anti-cancer drug treatment is the development of acquired multidrug resistance (MDR) of the tumor cells. Verotoxin-1 (VT-1) exerts its cytotoxicity by targeting the globotriaosylceramide membrane receptor (Gb3), a glycolipid asso
Externí odkaz:
https://doaj.org/article/e6dbbee40b724c4692750caf3d594b4a
Autor:
Guido Kroemer, Maria Castedo, Jean-Charles Soria, Murat Saparbaev, Philippe Dessen, Catherine Brenner, Gen Sheng Wu, Kimitoshi Kohno, Parviz Behnam-Motlagh, Pauline Garcia, Abdul Qader Sukkurwala, Delphine Lissa, Cédric Oréar, Philippe Girard, Angélique Robin, Monique Talbot, David Pierre Enot, Justine Guegan, Ibtissam Talhaoui, Laura Senovilla, Oliver Kepp, Ken André Olaussen, Julien Adam, Lorenzo Galluzzi, Ilio Vitale, Judith Michels
PDF file - 490K, Supplementary Table S1. Systematic comparison of the effects of CDDP and PARP inhibitors on cancer cell lines used in this study. Supplementary Figure S1. Generation and characterization of CDDP-resistant human NSCLC cell clones. Sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65cc071c79c2ef3428fba45e85da2ba9
https://doi.org/10.1158/0008-5472.22399542.v1
https://doi.org/10.1158/0008-5472.22399542.v1
Autor:
Parviz Behnam-Motlagh, Kjell Grankvist, Mary F. Rooney, Emma B. O’Connor, Karima Khalifa, Robert J. Buckland, Torbjörn K. Nilsson, Richard K. Porter, Fintan Geoghegan, Eric T. Rogers
Publikováno v:
Oncotarget
// Fintan Geoghegan 1 , Robert J. Buckland 2 , Eric T. Rogers 1 , Karima Khalifa 1 , Emma B. O’Connor 1 , Mary F. Rooney 1 , Parviz Behnam-Motlagh 2 , Torbjorn K. Nilsson 2 , Kjell Grankvist 2 and Richard K. Porter 1 1 School of Biochemistry and Im
Autor:
Maria Castedo, Ilio Vitale, Parviz Behnam-Motlagh, Pauline Garcia, Catherine Brenner, Judith Michels, Guido Kroemer, Florine Obrist, Kimitoshi Kohno, Gen Sheng Wu, Delphine Lissa
Publikováno v:
Biochemical Pharmacology. 92:55-61
The selection of human cancer cell lines in cis-diamminedichloroplatinum(II) (CDDP, best known as cisplatin) is accompanied by stereotyped alterations that contribute to the acquisition of a CDDP-resistant state. Thus, CDDP resistance often leads to
Publikováno v:
Epigenetics. 9:1149-1162
In order to obtain a comprehensive DNA methylation signature of HER2-positive breast cancer (HER2+ breast cancer), we performed a genome-wide methylation analysis on 17 HER2+ breast cancer and compared with ten normal breast tissue samples using the
Publikováno v:
British Journal of Cancer
Background: A major problem with cisplatin treatment is the development of acquired-drug resistance of the tumour cells. Verotoxin-1 (VT-1) exerts its cytotoxicity by targeting the membrane glycolipid globotriasosylceramide (Gb3), a molecule associat
Publikováno v:
Pharmacology & Toxicology. 88:244-249
Autor:
Roger Henriksson, Veronica Janson, Karl Gunnar Engström, Kjell Grankvist, Britta Andersson, Parviz Behnam-Motlagh
Publikováno v:
Cellular Physiology and Biochemistry. 22:045-056
Aims: Resistance mechanisms are important limiting factors in the treatment of solid malignancies with cis-diamminedichloroplatinum(II) (cisplatin). To gain further understanding of the effects of acquired cisplatin-resistance, we compared a human ma
Autor:
Parviz Behnam-Motlagh, Roger Henriksson, Ulrika Andersson, Per Bergström, David Johansson, Thomas Brännström, Kjell Grankvist, Anders Johansson
Publikováno v:
Cancer Biology & Therapy. 5:1211-1217
The aim of this study was to examine the cytotoxicity and mechanism of apoptosis induction of verotoxin-1 (VT-1) in human glioma cell lines. VT-1 is a member of the shiga-toxin family expressed by some serotypes of Escherichia coli and Shigella dysen